CTRI/2026/07/113530进行中（未招募）Phase 3 4
A Single group open label clinical trial to evaluate the efficacy and safety of Najlant powder in the management of Allergic rhinitis - NIL
Sandipani Healthcare Private Limited0 个研究点目标入组 40 人开始时间: 2026年7月16日最近更新:
试验速览
- 阶段
- Phase 3 4
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adults aged 18 to 65 years
- •Diagnosed cases of Allergic rhinitis
- •History of recurrent cold or seasonal allergy
- •Willig to give written informed consent
排除标准
- •Severe respiratory illness or pneumonia
- •Chronic lung disease requiring hospitaliszation
- •Severe systemic illness
- •Pregnant or lactating women
研究者
相似试验
已完成
2/3 期
Interventional Study To Evaluate The Effect Of An Ayurvedic Tablet, Cream And Purgative Therapy On The Participants Of Psoriasis(Skin Condition)CTRI/2024/05/067843NO SPONSER30
尚未招募
Unknown
efficacy of Shuddhi Dr. Sukoon Tablets in patients having Stress Issues.CTRI/2025/07/091819Jeena Sikho Lifecare Limited35
尚未招募
2/3 期
A Clinical Trial On Hyperacidity With Patolnimabadi Kashaya.CTRI/2024/04/065887Dr Naiyaben Ashishkumar Patel30
尚未招募
4 期
An Open Label Clinical Trial to Assess the Effectiveness of Nabhi Oil Application in Adults with AgnimandyaCTRI/2026/03/105129Ved Sanjeevani Pvt Ltd60
尚未招募
1 期
A Study to Evaluate the Efficacy and Safety of Intravesical Instillation of Disitamab Vedotin Combined With Toripalimab in Patients With HER2-Positive High-Risk Non-Muscle Invasive Bladder Cancer Who Are BCG-Naïve or Have BCG FailureBladder CancerNCT07783815Xiangya Hospital of Central South University20